Trial CO. / AEs / AGITG CO. / New England Journal / Amgen Australia Pty Ltd / EPIC / CTG CO. / ITT / /
Country
Spain / /
Currency
USD / /
Event
FDA Phase / /
IndustryTerm
Treatment of Metastatic Colorectal Cancer / treatment of metastatic EGFR-positive colorectal cancer / treatment of colorectal cancer / /
MarketIndex
PBS / /
MedicalCondition
RAS wild-type metastatic colorectal cancer / hypertension / cancer / advanced colorectal cancer / dermatitis / progressive disease / neutropenia / nausea / metastatic colorectal cancer / vomiting / fatigue / panitumumab Cancer / KRAS wild-type metastatic colorectal cancer / metastatic colorectal cancer Price et al Bennet et al Sartore-Bianchi / metastatic colorectal cancer receiving cetuximab / rash / K-RAS wild-type metastatic colorectal cancer / chronic conditions / /
MedicalTreatment
chemotherapy / /
Organization
World Health Organization / World Congress / National Science Foundation / Private Hospital/Private Clinic Authority / Chemotherapy Private Hospital/Private Clinic Authority Required and Public Hospital Authority / American Society of Clinical Oncology / Public Hospital Authority / Medicare / /
Microsoft WordPanitumumab Amgen PSD March 2013 FINAL .docx